Factors associated with loss to follow-up among women in Option B+ PMTCT programme in northeast Ethiopia: a retrospective cohort study

INTRODUCTION: Ethiopia has recently adopted lifelong antiretroviral therapy (ART) for all HIV-positive pregnant and breastfeeding women (Option B+ strategy), regardless of CD4 count or clinical stage. However, the exact timing and predictors of loss to follow-up (LFU) are unknown. Thus, we examined...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitiku, Israel, Arefayne, Mastewal, Mesfin, Yonatal, Gizaw, Muluken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803835/
https://www.ncbi.nlm.nih.gov/pubmed/27005750
http://dx.doi.org/10.7448/IAS.19.1.20662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803835/
https://www.ncbi.nlm.nih.gov/pubmed/27005750
http://dx.doi.org/10.7448/IAS.19.1.20662

Ejemplares similares